Peritoneal Immune System in Patients with Advance Epithelial Ovarian Cancer

被引：12

作者：

Wertel, Iwona ^{[1
]}

Nowicka, Aldona ^{[1
]}

Rogala, Ewelina ^{[1
]}

Kotarski, Jan ^{[1
]}

机构：

[1] Med Univ, Chair & Dept Oncol Gynaecol & Gynaecol 1, PL-20950 Lublin, Poland

来源：

INTERNATIONAL REVIEWS OF IMMUNOLOGY | 2011年 / 30卷 / 2-3期

关键词：

ovarian cancer; peritoneal cavity; dendritic cells; tumor-infiltrating cells; ENDOTHELIAL GROWTH-FACTOR; REGULATORY T-CELLS; TUMOR-INFILTRATING LYMPHOCYTES; PLASMACYTOID DENDRITIC CELLS; SUPPRESSOR-CELLS; PERIPHERAL-BLOOD; ASCITIC FLUID; IMMUNOSUPPRESSIVE NETWORKS; PROGNOSTIC-SIGNIFICANCE; VASCULAR LEUKOCYTES;

D O I：

10.3109/08830185.2011.569902

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The development of epithelial ovarian cancer is associated with changes in the peritoneal cavity microenvironment. Tumor cells produce different factors, which impairs differentiation, maturation, and function of antigen-presenting cells. In this review, we focus on selected cell populations in the peritoneal cavity immune system and their potential role in epithelial ovarian cancer immunopathogenesis. We devote most attention to dendritic cells because they are considered to be superior in their antigen-presenting ability, compared with both macrophages and B lymphocytes. We also present a brief characterization of tumor-infiltraiting cells in epithelial ovarian cancer patients.

引用

页码：87 / 101

页数：15

共 50 条

[1] Plasma immune analytes in patients with epithelial ovarian cancer
Block, Matthew S.
Maurer, Matthew J.
Goergen, Krista
Kalli, Kimberly R.
Erskine, Courtney L.
Behrens, Marshall D.
Oberg, Ann L.
Knutson, Keith L.
CYTOKINE, 2015, 73 (01) : 108 - 113
[2] Phase II trial of irinotecan in patients with metastatic epithelial ovarian cancer or peritoneal cancer
Bodurka, DC
Levenback, C
Wolf, JK
Gano, J
Wharton, JT
Kavanagh, JJ
Gershenson, DM
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (02) : 291 - 297
[3] LINEAR RELATIONSHIP OF PERITONEAL CANCER INDEX AND SURVIVAL IN PATIENTS WITH EPITHELIAL OVARIAN CANCER IN CARCINOMATOSIS
Roosen, A.
Sanson, C.
Faron, M.
Maulard, A.
Pautier, P.
Leary, A.
Chargari, C.
Genestie, C.
Zaccarini, F.
Scherier, S.
Morice, P.
Gouy, S.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A291 - A292
[4] Peritoneal Mechanobiology and Metastatic Success in Epithelial Ovarian Cancer
Burkhalter, Rebecca J.
Liu, Yueying
Marszow, Michael
Sun, Zhe
Meininger, Gerald
Wagner, Diane
Stack, M. Sharon
FASEB JOURNAL, 2012, 26
[5] Peritoneal inflammation - A microenvironment for epithelial ovarian cancer (EOC)
Freedman R.S.
Deavers M.
Liu J.
Wang E.
Journal of Translational Medicine, 2 (1)
[6] Peritoneal mechanobiology and metastatic success in epithelial ovarian cancer
Burkhalter, Rebecca J.
Liu, Yueying
Marszow, Michael
Sun, Zhe
Meininger, Gerald
Wagner, Diane
Stack, M. Sharon
CANCER RESEARCH, 2012, 72
[7] Development of Peritoneal Carcinomatosis in Epithelial Ovarian Cancer: A Review
van Baal, Juliette O. A. M.
van Noorden, Cornelis J. F.
Nieuwland, Rienk
Van de Vijver, Koen K.
Sturk, Auguste
van Driel, Willemien J.
Kenter, Gemma G.
Lok, Christianne A. R.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2018, 66 (02) : 67 - 83
[8] Comprehensive management of epithelial ovarian cancer with peritoneal metastases
Luigi Frigerio
Luca Ansaloni
Elia Poiasina
Federico Coccolini
Paul H Sugarbaker
World Journal of Obstetrics and Gynecology, 2013, (04) : 108 - 115
[9] The Risk of Ovarian Malignancy Algorithm (ROMA) as a Predictive Marker of Peritoneal Dissemination in Epithelial Ovarian Cancer Patients
Ikeda, Yuji
Hasegawa, Kosei
Kurosaki, Akira
Miyara, Akiko
Hanaoka, Tatsuya
Shintani, Daisuke
Imai, Yuichi
Nishikawa, Tadaaki
Oda, Katsutoshi
Fujiwara, Keiichi
ONCOLOGY RESEARCH AND TREATMENT, 2015, 38 (06) : 276 - 281
[10] Immune regulation in endometriosis and epithelial ovarian cancer
Mantia-Smaldone, G.
Budiu, R.
Mansuria, S.
Lee, T.
Zorn, K.
Elishaev, E.
Edwards, R.
Vlad, A.
GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S114 - S114

← 1 2 3 4 5 →